Search Browse Earnings

Zenas BioPharma, Inc. — SlamSEC

Zenas BioPharma, Inc.

Nasdaq:ZBIO

Pharmaceutical Preparations·WALTHAM, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$5.0M

-90.0% YoY

FY 2025

Adj. EBITDA

-$163.8M

-3275.0% margin

FY 2025

Net Income

-$157.0M

-3139.8% margin

FY 2025

EPS (Diluted)

-$11.89

FY 2025

Stock Price

$22.30

-4.6%

2026-03-20

52W Range

$6.11 – $44.60

P/E Ratio

-1.9x

Market Cap

$1.3B

Cash

$319.7M

FY 2025

Total Debt

$78.6M

FY 2025

Net Cash

$241.1M

FY 2025

Enterprise Value

$1.0B

Debt / EBITDA

1.5x

FY 2025

EV / EBITDA

-6.3x

Employees

—

CEO

Moulder Leon O Jr